Method of inhibiting insulin-like growth factor-1 (IGF-1) by IGF-1-antagonist peptides

摘要

Peptides are provided that antagonize the interaction of IGF-1 with its binding proteins, insulin receptor, and IGF receptor. These IGF antagonist peptides are useful in treating disorders involving IGF-1 as a causative agent, such as, for example, various cancers.